Tempus AI (NASDAQ:TEM) Receives New Coverage from Analysts at Bank of America

Bank of America started coverage on shares of Tempus AI (NASDAQ:TEMFree Report) in a report published on Tuesday morning, MarketBeat.com reports. The firm issued a buy rating and a $41.00 target price on the stock.

A number of other research firms have also weighed in on TEM. Needham & Company LLC began coverage on shares of Tempus AI in a research note on Tuesday. They issued a buy rating and a $47.00 price objective for the company. JPMorgan Chase & Co. began coverage on shares of Tempus AI in a research note on Tuesday. They issued an overweight rating and a $42.00 price objective for the company. Loop Capital began coverage on shares of Tempus AI in a research note on Tuesday. They issued a buy rating and a $48.00 price objective for the company. Stifel Nicolaus began coverage on shares of Tempus AI in a research note on Tuesday. They issued a buy rating and a $45.00 price objective for the company. Finally, Morgan Stanley began coverage on shares of Tempus AI in a research note on Tuesday. They issued an overweight rating and a $44.00 price objective for the company. Nine investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has an average rating of Buy and a consensus price target of $45.63.

Read Our Latest Stock Report on TEM

Tempus AI Stock Up 3.9 %

NASDAQ TEM opened at $34.50 on Tuesday. Tempus AI has a 12 month low of $22.89 and a 12 month high of $43.88.

Tempus AI Company Profile

(Get Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Read More

Analyst Recommendations for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.